V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10396037 | 10040900 | 1.67 | 39.35 | Palliative (P) | 2020-04-20 | 2020-05-02 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 101297943 |
| 10396056 | 10040901 | null | 0 | null | 2015-10-08 | 2015-10-21 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100545886 |
| 10396057 | 10040902 | 1.65 | 78 | 03 | 2018-11-10 | 2018-12-15 | Folfirinox/ Folfoxiri | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100740484 |
| 10396318 | 10040905 | 0 | 0 | Neo-adjuvant (N) | 2019-10-16 | 2019-10-25 | FLUOROURACIL | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100462041 |
| 10396341 | 10040906 | null | null | 03 | 2016-08-26 | 2016-08-26 | CYTARABINE | 02 | N | CVP R | 101381368 |
| 10396460 | 10040907 | 1.78 | 87.4 | null | 2018-12-10 | 2018-12-10 | Busulfan Oral | null | null | DARATUMUMAB | 101187995 |
| 10396463 | 10040908 | 1.52 | 70 | Curative (C) | 2019-02-28 | 2019-03-01 | Carboplatin + Pembrolizumab + Pemetrexed | 99 | N | BCG | 100299489 |
| 10396488 | 10040909 | 1.79 | 67.5 | 03 | 2017-10-21 | 2017-10-29 | CHLORAMBUCIL + RITUXIMAB | 02 | N | CHLORAMBUCIL + RITUXIMAB | 100239012 |
| 10396550 | 10040910 | null | null | null | 2020-01-07 | 2020-01-26 | CISPLATIN + FLUOROURACIL | 02 | null | SUNITINIB | 101322404 |
| 10396807 | 10040911 | 1.72 | 67.2 | Palliative (P) | 2018-12-06 | 2018-12-09 | Mitomycin Intravesical | 99 | N | MITOMYCIN INTRAVESICULAR | 101608310 |
| 10396842 | 10040912 | null | 83.7 | Adjuvant (A) | 2018-01-15 | 2018-01-27 | Irinotecan + Modified De Gramont | null | Y | FLUOROURACIL + IRINOTECAN | 101827458 |
| 10396859 | 10040913 | 1.61 | 89.1 | null | 2016-08-02 | 2016-08-30 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 2 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100490252 |
| 10396879 | 10040914 | 1.67 | 88.8 | Curative (C) | 2018-10-21 | 2018-11-18 | Palbociclib | 02 | N | PALBOCICLIB | 100147255 |
| 10396943 | 10040916 | 1.81 | 91 | null | 2018-04-22 | 2018-05-03 | Trial Unspecified | 02 | N | CYTARABINE | 101240498 |
| 10396967 | 10040917 | 1.65 | 44.4 | null | 2020-02-16 | 2020-02-17 | CLADRIBINE | 02 | null | CAPECITABINE + GEMCITABINE | 100624856 |
| 10397323 | 10040921 | 1.86 | 59.4 | Adjuvant (A) | 2017-02-19 | 2017-02-19 | Palbociclib | 02 | N | PALBOCICLIB | 101420043 |
| 10397335 | 10040922 | null | null | null | 2020-01-03 | 2020-01-03 | Trial Unspecified | 2 | null | DARATUMUMAB | 100476815 |
| 10397336 | 10040923 | 1.6 | 74.7 | Palliative (P) | 2020-01-11 | 2020-01-19 | Sunitinib | 02 | N | TRIAL | 100623538 |
| 10397352 | 10040924 | null | null | null | 2018-12-06 | 2018-12-10 | null | 02 | null | MITOMYCIN | 100668958 |
| 10397367 | 10040925 | 1.8 | 67.5 | Palliative (P) | 2017-02-20 | 2017-02-20 | BORTEZOMIB + THALIDOMIDE | 02 | null | BORTEZOMIB + THALIDOMIDE | 101497066 |
| 10397511 | 10040928 | 1.82 | 60.4 | Palliative (P) | 2018-03-17 | 2018-03-17 | BORTEZOMIB + THALIDOMIDE | 02 | N | BORTEZOMIB + THALIDOMIDE | 100559080 |
| 10397590 | 10040929 | 1.54 | 76.6 | 03 | 2017-09-10 | 2017-09-24 | R GCVP | 02 | N | CYTARABINE | 100093561 |
| 10397618 | 10040930 | 1.76 | 83 | null | 2019-05-30 | 2019-06-21 | Mitomycin Intravesical | 02 | null | MITOMYCIN INTRAVESICULAR | 101547259 |
| 10397620 | 10040931 | 1.76 | 65.4 | Palliative (P) | 2018-06-15 | 2018-06-30 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100064934 |
| 10397916 | 10040933 | null | 0 | 03 | 2018-08-19 | 2018-08-19 | BORTEZOMIB + THALIDOMIDE | 02 | N | BORTEZOMIB + THALIDOMIDE | 101849515 |
| 10397960 | 10040934 | 1.55 | 85.3 | 03 | 2019-05-28 | 2019-06-11 | Venetoclax | 02 | N | CAPECITABINE + GEMCITABINE | 100798272 |
| 10398021 | 10040935 | 1.8 | 53.9 | Palliative (P) | 2019-02-17 | 2019-02-25 | CYCLOPHOSPHAMIDE + RITUXIMAB | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB | 101556461 |
| 10398042 | 10040936 | 1.53 | 61.1 | null | 2022-05-14 | 2022-05-22 | BCG Intravesical | 02 | null | CVP R | 101326780 |
| 10398118 | 10040937 | 1.6 | 79.8 | Palliative (P) | 2019-08-28 | 2019-09-11 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100029988 |
| 10398157 | 10040938 | 1.62 | 100 | Adjuvant (A) | 2017-08-21 | 2017-08-28 | FEC 60 or 75 | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100801431 |
| 10398298 | 10040939 | 1.8 | 73.8 | 03 | 2018-05-28 | 2018-05-28 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100851036 |
| 10398434 | 10040940 | 1.55 | 82.2 | Palliative (P) | 2018-01-04 | 2018-01-28 | Carboplatin + Vinorelbine Oral | 02 | N | CARBOPLATIN + VINORELBINE | 101642594 |
| 10398597 | 10040942 | 1.56 | 54 | Neo-adjuvant (N) | 2015-06-22 | 2015-06-23 | Mitomycin Intravesical | N | N | MITOMYCIN INTRAVESICULAR | 101324660 |
| 10398606 | 10040943 | 1.62 | 69.9 | Curative (C) | 2018-02-24 | 2018-02-24 | MUK 5 TRIAL | 02 | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 101834453 |
| 10398750 | 10040944 | 1.72 | 77 | Palliative (P) | 2012-02-17 | 2018-08-29 | Capecitabine + Cisplatin | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100784661 |
| 10398787 | 10040945 | 1.58 | 70.4 | Curative (C) | 2017-08-17 | 2017-08-24 | FEC + DOCETAXEL | N | N | CVP R | 101025961 |
| 10398799 | 10040946 | 1.77 | 59.3 | Palliative (P) | null | 2018-01-18 | Avelumab | null | N | AVELUMAB | 100281806 |
| 10398814 | 10040948 | 1.64 | 98 | Palliative (P) | null | 2018-01-11 | Folfirinox/ Folfoxiri | 02 | null | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 101080109 |
| 10398833 | 10040949 | 1.73 | 61 | null | null | 2020-03-06 | Venetoclax | 02 | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 101614998 |
| 10399016 | 10040951 | 1.8 | 72 | Adjuvant (A) | 2018-01-04 | 2018-01-12 | DABRAFENIB + TRAMETINIB | 02 | N | DARATUMUMAB | 100184928 |
| 10399169 | 10040952 | 1.77 | 87.4 | 03 | 2018-07-26 | 2018-07-27 | Capecitabine + Cisplatin | 01 | N | CVP R | 101588051 |
| 10399228 | 10040953 | 1.72 | 74.6 | Palliative (P) | 2018-03-01 | 2018-03-25 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100427280 |
| 10399465 | 10040954 | 1.62 | 59 | 03 | 2021-04-20 | 2021-05-03 | BORTEZOMIB + THALIDOMIDE | N | N | BORTEZOMIB + THALIDOMIDE | 101686926 |
| 10399600 | 10040955 | 1.62 | 75 | 03 | 2018-01-08 | 2018-01-25 | BCG Intravesical | 02 | N | CISPLATIN + FLUOROURACIL | 100164883 |
| 10399749 | 10040956 | 1.78 | 0 | Adjuvant (A) | 2017-09-23 | 2017-09-26 | CARBOPLATIN + VINORELBINE | 02 | N | CARBOPLATIN + VINORELBINE | 101135681 |
| 10399766 | 10040957 | 0 | 0 | Palliative (P) | 2017-01-19 | 2017-01-23 | Palbociclib | 2 | N | PALBOCICLIB | 101362517 |
| 10399803 | 10040958 | 1.72 | 55 | null | 2019-12-07 | 2019-12-17 | CTD Attenuated (Thalidomide 50mg) | 02 | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100479259 |
| 10399913 | 10040959 | 1.88 | 67 | Palliative (P) | 2019-06-07 | 2019-06-07 | CHOP R - 21 days | 02 | N | CHOP R | 101771462 |
| 10400065 | 10040960 | 1.73 | null | null | 2022-05-05 | 2022-05-22 | BORTEZOMIB + THALIDOMIDE | 02 | null | BORTEZOMIB + THALIDOMIDE | 101611466 |
| 10400171 | 10040962 | 1.66 | 65 | Palliative (P) | 2020-04-10 | 2020-04-30 | Pazopanib | 02 | N | CISPLATIN + VINORELBINE | 100855241 |